parkinson's%20disease%20-and-%20parkinson's%20disease%20dementia
PARKINSON'S DISEASE & PARKINSON'S DISEASE DEMENTIA

Parkinson's disease is a progressive neurodegenerative disorder that is common, age-related and chronic.

It is caused by loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain.

Onset of symptoms and progression of the disease is gradual.

Motor signs and symptoms include resting tremor, rigidity, bradykinesia and postural instability.

Parkinson's disease dementia indicates loss of intellectual functions including memory, significant deterioration in the ability to carry out day-to-day activities and changes in social behavior are often noted.

Parkinson's%20disease%20-and-%20parkinson's%20disease%20dementia Signs and Symptoms

Introduction

  • Parkinson's Disease (PD) is a common, age-related, chronic, progressive disorder caused by loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain
  • Pathologic hallmark is loss of dopaminergic substantia nigra neurons with surviving neurons often containing a characteristic cytoplasmic inclusion body (Lewy body)
  • Increased prevalence and incidence rates are noted in the elderly
  • Men have higher incidence rate, with relative risk 1.5 times more than in women

Signs and Symptoms

  • Early symptoms are subtle and occur gradually

Motor signs and symptoms

  • Resting tremor
  • Rigidity
  • Bradykinesia
  • Postural instability

Nonmotor signs and symptoms

  • Autonomic (eg gastrointestinal dysfunction, urinary and sexual dysfunction, orthostatic hypotension, hyperhidrosis)
  • Sleep disorders (eg impaired sleep initiation and maintenance, rapid eye movement sleep behavior disorder and excessive daytime sleepiness)
  • Sensory (eg pain, hyposmia, visual dysfunction)
  • Neuropsychiatric (eg depression, anxiety and panic attacks, dementia, psychosis)
Editor's Recommendations
Most Read Articles
Stephen Padilla, 6 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
6 days ago
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 2 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.